Buscar

Mostrando ítems 1-10 de 31

Body Composition And Bone Mineral Density In Users Of The Etonogestrel-releasing Contraceptive Implant.

Modesto, Waleska; Dal Ava, Natália; Monteiro, Ilza; Bahamondes, Luis (2015)

Factores que influyen en la deserción del uso del implante subdérmico etonogestrel. Período de estudio enero - julio 2019

Alcívar Espinar, Karen Stefanía (Universidad de Guayaquil. Facultad de Ciencias Médicas. Carrera de Obstetricia, 2019)

Teniendo presente que generalmente la mayor parte de métodos anticonceptivos ocasionan efectos adversos y entre estos los implantes subdérmicos, se realizó esta investigación con el propósito de determinar los factores que ...

Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study

BRITO, Milena Bastos; FERRIANI, Rui Alberto; QUINTANA, Silvana Maria; YAZLLE, Marta Edna Holanda Diogenes; SA, Marcos Felipe Silva de; VIEIRA, Carolina Sales (ELSEVIER SCIENCE INC, 2009)

Background: The effects of etonogestrel (ETG)-releasing contraceptive implant during the immediate postpartum period on maternal safety are unknown. Study design: Forty healthy women exclusively breastfeeding were randomized ...

Estudo prospectivo da densidade mineral ossea no antebraço de usuarias de implantes contraceptivos liberadores de etonogestrel ou levonorgestrel

Dantas, Maria Cecilia Monteiro ([s.n.], 2006)

Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: A randomized controlled trial

Brito, Milena B.; Ferriani, Rui A.; Meijers, Joost C. M.; Garcia, Andrea A.; Quintana, Silvana M.; Silva de Sa, Marcos F.; Vieira, Carolina S. (PERGAMON-ELSEVIER SCIENCE LTDOXFORD, 2013-08-02)

Introduction: The puerperium is the period of highest risk for thrombosis during a woman's reproductive life and it is an important time for initiating an effective contraceptive method in order to increase intergestational ...

Extended Use Up To 5 Years Of The Etonogestrel-releasing Subdermal Contraceptive Implant: Comparison To Levonorgestrel-releasing Subdermal Implant

Ali; Moazzam; Akin; Ayse; Bahamondes; Luis; Brache; Vivian; Habib; Ndema; Landoulsi; Sihem; Hubacher; David (Oxford Univ PressOxford, 2016)

Body Composition And Bone Mineral Density In Users Of The Etonogestrel-releasing Contraceptive Implant

Modesto; Waleska; DalAva; Natalia; Monteiro; Ilza; Bahamondes; Luis (SPRINGER HEIDELBERGHEIDELBERG, 2015)

Bleeding Patterns Of Hiv-infected Women Using An Etonogestrel-releasing Contraceptive Implant And Efavirenz-based Or Lopinavir/ritonavir-based Antiretroviral Therapy

Ragazini; Conrado S.; Bahamondes; Maria Valeria; Rocha Prandini; Tatiana R.; Brito; Milena Bastos; Amaral; Eliana; Bahamondes; Luis; Duarte; Geraldo; Quintana; Silvana Maria; Ferriani; Rui Alberto; Vieira; Carolina Sales (Taylor & Francis LtdAbingdon, 2016)

A 3-year Multicentre Randomized Controlled Trial Of Etonogestrel- And Levonorgestrel-releasing Contraceptive Implants, With Non-randomized Matched Copper-intrauterine Device Controls.

Bahamondes, Luis; Brache, Vivian; Meirik, Olav; Ali, Moazzam; Habib, Ndema; Landoulsi, Sihem; , (2015)

A Three-year Longitudinal Evaluation Of The Forearm Bone Density Of Users Of Etonogestrel- And Levonorgestrel-releasing Contraceptive Implants.

Monteiro-Dantas, Cecilia; Espejo-Arce, Ximena; Lui-Filho, Jeffrey F; Fernandes, Arlete M; Monteiro, Ilza; Bahamondes, Luis (2007)